NASDAQ$BTTC

Black Titan Corp · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Headline financials

Total Revenue

$4K

Previous: $95K-95.8%
EPS (adj)

-$0.40

Previous: -$3.60+88.9%
Capital Expenditures

$0.00

No prior period
Free Cash Flow

-$1.84M

No prior period
Net Income

-$338K

Previous: -$2.64M+87.2%
Operating Income

-$2.06M

Previous: -$2.64M+22.0%
Gross Profit

-$23K

Previous: -$928K+97.5%
Cash & Equivalents

$8.11M

Previous: $4.45M+82.2%
Total Assets

$10M

Previous: $6.28M+59.3%
R&D Expense

$424K

No prior period
Stock-Based Comp

$411K

Previous: $541K-24.0%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$4K

Q3 2023-95.8%vs Q3 2022
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro